Rahul Singhvi
CIK 1322731 · President, CEO · last filed 2025-11-26
Rahul Singhvi is a President, CEO who has filed 19 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for KAPA, was dated Nov 26, 2025. Across all open-market trades the lifetime net is −$769.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.08M
4
19
-$769.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KAPA | Director | 49,204 | $0.44 | $21.6K | $0 | 1 | 2025-11-26 |
| CDXS | Director | 137,052 | $2.40 | $328.9K | $0 | 5 | 2025-06-12 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Director | 15,000 | — | — | $0 | 5 | 2016-06-21 |
| NVAX | President, CEO | 194,838 | $8.88 | $1.73M | -$769.5K | 8 | 2011-03-14 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-26 | KAPA | Grant (A) | +19,084 | $0 | EDGAR |
| 2025-06-12 | CDXS | Grant (A) | +40,983 | $0 | EDGAR |
| 2024-06-13 | CDXS | Grant (A) | +30,120 | $0 | EDGAR |
| 2023-11-14 | CDXS | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | CDXS | Grant (A) | +34,602 | $0 | EDGAR |
| 2022-09-30 | CDXS | Grant (A) | +31,347 | $0 | EDGAR |
| 2016-06-21 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-22 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2015-06-30 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-09-24 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | — | $0 | EDGAR |